Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Trimethoprim
Chemidex Pharma Limited
J01EA; J01EA01
Trimethoprim
10 milligram(s)/millilitre
Oral suspension
Product subject to prescription which may not be renewed (A)
Trimethoprim and derivatives; trimethoprim
Marketed
1982-04-16
31017370.05 IR2-1/L/h/8a _Continued over page_ Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. Package leaflet: Information for the user Monotrim 10 mg/ml Oral Suspension trimethoprim SEEK IMMEDIATE MEDICAL ATTENTION IF YOU HAVE ANY OF THE FOLLOWING SYMPTOMS: eye pain, redness, or sensitivity to bright light, blurred vision, floaters (dots that move across the field of vision) sudden headache, stiff neck, fever, sensitivity to bright light, drowsiness and muscle pain, with or without a rash unusual bleeding or bruising; repeated infections or infections that will not go away. This may be due to changes in your blood. Blood tests may be carried out to check for this yellowing of the skin or whites of the eyes caused by liver or blood problems . TELL YOUR DOCTOR IF YOU GET ANY OF THE FOLLOWING SIDE EFFECTS: muscle pain or muscle weakness nausea, vomiting or an upset stomach reactions to the sun. Skin may become red, painful and swollen - do not sunbathe, use a sun bed, or expose your skin to UV light. Some people may get an increased amount of potassium in their blood (especially the elderly or those with kidney problems). You cannot feel or see this but your doctor may test your blood for this side effect. REPORTING OF SIDE EFFECTS If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance Earlsfort Terrace IRL - Dublin 2 Tel: +353 1 6764971 Fax: +353 1 Прочитајте комплетан документ
Health Products Regulatory Authority 27 February 2019 CRN008QQG Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Monotrim 10 mg/ml Oral Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 10 mg trimethoprim. Excipients with known effect: Each ml of this medicine contains 408 mg sorbitol, 1.3 mg methyl parahydroxybenzoate and 0.85 mg sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. White, homogenous suspension with odour of aniseed. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of infections caused by trimethoprim-sensitive organisms including urinary and respiratory tract infections and prophylaxis of recurrent urinary tract infections. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology 1. Treatment of respiratory and urinary tract infections: _Adults and children over 12 years:_ The usual dosage is 200 mg (four 5 ml spoonfuls) twice daily for 7-10 days. _Paediatric population (under 12 years):_ Based on 6 mg/kg/day in two divided dosages as follows: _ _ _6 weeks to 5 months: _ 25 mg (half a 5 ml spoonful) twice daily for 7-10 days. _6 months to 3 years (8-15 kg):_ 25-50 mg (half to one 5 ml spoonful) twice daily for 7-10 days. _4-7 years (15-25 kg):_ 50-75 mg (one to one-and-a-half 5 ml spoonfuls) twice daily for 7- 10 days. _8-12 years (25-40 kg):_ 75-125 mg (one-and-a-half to two-and-a-half 5 ml spoonfuls) twice daily for 7-10 days. The first dosage on the first day can be doubled. 2. Prophylaxis of recurrent urinary tract infection: _ _ _Adults and children over 12 years: _The usual dose is 100 mg (two 5 ml spoonfuls) at night. An extra 100 mg may be taken in the morning, if necessary. _Paediatric population under 12 years_: 2.5 mg/kg/day once daily in the evening. Health Products Regulatory Authority 27 February 2019 CRN008QQG Page 2 of 6 3. Dosage in renal impairment: Creatinine clearance (ml/sec) Plasma creatinine (micromol/l) Dosage advised Over 0.45 men < 250 women < 175 normal 0.25–0.45 men Прочитајте комплетан документ